This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Analysts' Actions: ADTN CMI COG DRI MSFT

Supernus Pharmaceuticals (SUPN) was initiated with a buy rating at Lazard. $16 price target. New epilepsy drugs should drive growth, Lazard said.

Tibco (TIBX) was downgraded at Bank of America/Merrill Lynch from buy to neutral. $26 price target. Company is seeing lower results across the board, BofA/Merrill said.

WABCO (WBC) was downgraded at William Blair to market perform from outperform. Valuation call and potential downward EPS revisions, Blair said. $65 price target.

Wesco (WCC) was downgraded at FBR Capital Markets from outperform to market perform. $66 price target. Stock also cut from Top Picks list. Lower organic growth may cut into margins over the coming quarters, FBR Capital Markets said.

Whitewave Foods (WWAV) was initiated with a buy rating at Bank of America/Merrill Lynch. $18 price target. Company can grow twice as fast as its peers, BofA/Merrill said.


Altera Corp (ALTR) numbers lowered at Jefferies. Shares of ALTR now seen reaching $35, Jefferies said. Estimates also lowered on mid- quarter update. Hold rating.

Darden Restaurants (DRI - Get Report) numbers cut at UBS. Shares of DRI now seen reaching $52, UBS said. Estimates also lowered on negative F2Q preannouncement. Buy rating.

Baker Hughes (BHI) estimates reduced at Guggenheim through 2013, Guggenheim said. Company is seeing slower international demand. Neutral rating and $50 price target.

Edwards Lifesciences (EW) numbers raised at Citigroup. Shares of EW now seen reaching $98, Citigroup said. Estimates also increased on greater US TAVI revenues. Neutral rating.

Coca-Cola (KO) estimates lowered at JP Morgan through 2013, JP Morgan said. Company is leveraged to slower international growth. Neutral rating and $43 price target.

Mattress Firm (MFRM) numbers cut at Keybanc. MFRM estimates were reduced through 2013, Keybanc said. Company is facing increased competition. Buy rating and new $34 price target.

Microsoft (MSFT) estimates, target cut at MKM. Shares of MSFT now seen reaching $28, according to MKM Partners. Estimates also reduced, as recent checks show lower demand for Windows 8 Surface.

Vail Resorts (MTN) numbers reduced at JMP. MTN estimates were cut through 2013, JMP Securities said. Company has had a slow start to its season. Outperform rating and new $60 price target.

Regal Beloit (RBC) numbers boosted at JMP. Shares of RBC now seen reaching $78, according to JMP Securities. Estimates also upped, as new products should help drive growth over the coming quarters. Outperform rating.

AT&T (T) estimates trimmed at Citigroup through 2013, Citigroup said. Accelerated network investments. $39 price target and Buy rating.

TIBCO Software (TIBX) numbers lowered at Jefferies. Shares of TIBX now seen reaching $25, Jefferies said. Estimates also lowered on weakness throughout BI/data analytics. Buy rating.

>To submit a news tip, email:


Follow TheStreet on Twitter and become a fan on Facebook.
This article was written by a staff member of TheStreet.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
ADTN $19.32 0.00%
CMI $117.03 0.00%
COG $23.40 0.00%
DRI $62.25 0.00%
LMCA $18.30 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs